| Similar Articles |
|---|
 |
Chemistry World
September 3, 2014
Rajesh Parishwad |
Piramal exits drug discovery in India India's Piramal Enterprises is exiting its early-stage drug discovery research and focusing on late clinical development, along with its core areas such as generics and contract research services.   |
BusinessWeek
April 18, 2005
Manjeet Kripalani |
India: Bigger Pharma Tougher patent protection laws are spurring rapid growth in new drug research across India. |
Pharmaceutical Executive
June 1, 2012 |
2012 Dealmakers Outlook With Yankee Stadium as the backdrop, Pharm Exec convened on its annual panel of heavy hitters in business development to crack the bat on best practices in licensing and for the year ahead. |
Pharmaceutical Executive
September 1, 2013
William Looney |
High Noon For Hot Markets Fading growth, overstretched governments, and a global governance backlash against pharma business are turning up the heat on the performance of emerging country markets. |
Pharmaceutical Executive
August 1, 2011
Ben Comer |
Is the 'Emerging Market' a Dated Concept? When it comes to the emerging markets, executing a few key elements of success are more important than ever. |
Pharmaceutical Executive
December 1, 2010
Walter Armstrong |
The Next Wave: Pharm Exec's 2011 Pipeline Report 42 of the best new drugs in development or parked at the FDA |
Pharmaceutical Executive
April 1, 2012 |
Leading from the South India's most prominent scientist sets a new agenda for pharma in emerging markets. |
Pharmaceutical Executive
October 1, 2010 |
Taking a Less-Generic Route to Generics A leading pharmaceutical industry player speaks out on what is fueling success in the sector. |
Pharmaceutical Executive
July 3, 2007 |
Thought Leader: Connected Markets, Rob Dhoble It used to be that pharma companies had one marketing strategy for the US and other developed nations, a second strategy for emerging countries, and a third, mostly focused around access, for the developing world. But in a global environment, that doesn't work. |
Pharmaceutical Executive
July 3, 2007 |
Harbingers of Change What to watch, and watch out for, in the bottom half of '07. The IMS Health Editorial Board identifies what it believes are the key events that will impact the global pharmaceutical market in the near future. |
BusinessWeek
January 12, 2004
Manjeet Kripalani |
India: Big Pharma's New Promised Land? Drugmakers are heeding the siren call of its well-trained, cheap chemists. |
Pharmaceutical Executive
May 1, 2011
Cacciotti & Clinton |
12th Annual Pharm Exec 50 Pharm Exec's annual run-down of the world's biggest pharma companies. |
Pharmaceutical Executive
January 21, 2014
Tim Powell |
Innovation: The Moneyball Test Successful innovation now has to align with key metrics of value; can an old baseball metaphor help guide the way? |
Chemistry World
October 15, 2013
Dinsa Sachan |
Supreme court ruling brings clinical trials to a halt in India The fate of 162 global clinical trials hangs in the balance, as the top Indian court has asked the government to provide more details on their approval process before they can proceed. |
Pharmaceutical Executive
October 1, 2011
Amrita Ghaswalla |
Changing the Dialogue No industry leader is more closely associated with the goal of seeding the globe with low-cost generics than Mumbai-based Cipla Chairman Y.K. Hamied. |
Chemistry World
July 25, 2012 |
Pharma Industry May Suffer as India Looks to Generics India plans to provide free generic drugs to half its population. |
Wired
March 2006
Jennifer Kahn |
A Nation of Guinea Pigs There's a new outsourcing boom in South Asia - and a billion people are jockeying for the jobs. How India became the global hot spot for drug trials. |
The Motley Fool
May 21, 2010
Brian Orelli |
Abbott Learns to Say "Low Margin" in Hindi No matter what country, overpaying isn't a good idea. |
Pharmaceutical Executive
April 1, 2014
Subramanian et al. |
"Market-Based" Price Controls In India? Three strategic implications for pharma pricing strategies in India. |
Chemistry World
September 2009 |
Column: In the pipeline What's the most difficult therapeutic area for drug discovery? They're certainly not all created equal - or if they were, they have definitely diverged since then. The question can be narrowed down quite a bit. |
The Motley Fool
April 12, 2011
Brian Orelli |
Merck Joins the Low-Margin Party The American drugmaker announces that it is partnering with Sun Pharma to establish a joint venture to sell branded generics in emerging markets. |
BusinessWeek
October 10, 2005
Manjeet Kripalani |
India: A Quiet Shopping Spree So far, foreign companies being bought by Indian players are small - but that's likely to change |
Chemistry World
January 25, 2013
Rajesh Parishwad |
Indian supreme court's anger over unregulated clinical trials The fledgling clinical trials industry in India has been hit by recent revelations of a lack of regulation. Now, the country's supreme court has criticized the body that oversees clinical trials for its inaction in the face of these unethical practices. |
Chemistry World
February 3, 2015
Sanjay Kumar |
India's chemistry challenges While India is yet to catch up with the global cutting edge technologies, some of its interventions have made global headlines. |
Chemistry World
March 6, 2015
Sanjay Kumar |
Scientists left unimpressed by Indian budget The Indian government's 'big-bang' budget has left the country's science community sorely disappointed. |
IEEE Spectrum
November 2008
Hira & Ross |
R&D Goes Global Hidden in corporate research budgets is a shift of R&D work to low-cost countries, particularly China and India. |
BusinessWeek
December 8, 2003
Kripalani & Engardio |
The Rise Of India Growth is only just starting, but the country's brainpower is already reshaping Corporate America |
Chemistry World
February 12, 2015
S Umapathy |
Indian science at the crossroads How should Indian scientific research evolve? |
Chemistry World
October 17, 2014
Dinsa Sachan |
Indian manufacturers hit back over quality claims The Indian pharmaceutical industry has asked its government to sue authors of a study published by the US National Bureau of Economic Research in early September. |
IndustryWeek
December 1, 2008
Adrienne Selko |
The Rise Of Indian Manufacturing As India's production capabilities increase, U.S. manufacturers would do well to craft a global strategy that addresses the emergence of this no-longer-slumbering giant. |
Investment Advisor
October 2010
Savita Iyer-Ahrestani |
Jewels in the Crown As wealth mushrooms in India, the need for Western-style advice grows |
National Real Estate Investor
February 1, 2006
Jennifer Popovec |
New Land of Opportunity India is transforming from an exotic locale to the next frontier for American commercial real estate investment. In fact, real estate investment is expected to capture about 18% to 20% of all the money that is coming to India this year from outside its borders. |
The Motley Fool
March 10, 2011
Isac Simon |
India Prepared for $1 Trillion in Infrastructure Spending The Indian budget finally organizes a framework for foreign investments. |
